Navigation Links
Watson Promotes David Buchen, R. Todd Joyce to Executive Vice President
Date:3/9/2011

MORRISTOWN, N.J., March 9, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a global integrated pharmaceutical company, announced today that David A. Buchen has been promoted to Executive Vice President, General Counsel and Secretary, and R. Todd Joyce has been promoted to Executive Vice President, Chief Financial Officer.  Both continue to report to Paul M. Bisaro, President and Chief Executive Officer.

"These promotions not only recognize the substantial individual contributions David and Todd have made to Watson's ongoing success, but also the significant achievements made by both in building the teams that support our Company's global growth," said Bisaro.  "With the increasing complexity of our global portfolio – generics, brands and biologics – our international legal team has been increasingly called upon under David's leadership to support a broad array of competitive, compliance and intellectual property legal activities.  Todd and his team have ensured the seamless integration of our global finance operations following the Arrow acquisition, and demonstrated the leadership required to manage our global finances which have allowed us to deliver on our financial commitments while maintaining our capacity for continued growth and expansion.  Both promotions are well deserved and reflect the importance of these functions and the role of these two leaders in our success."

Mr. Joyce was appointed Senior Vice President, Chief Financial Officer of Watson in October 2009. He joined Watson in 1997 as Corporate Controller and was named Vice President, Corporate Controller and Treasurer in 2001. During the periods October 2006 to November 2007 and from July 2009 until October 2009, Mr. Joyce served as interim Principal Financial Officer.

Prior to joining Watson, Mr. Joyce served as Vice President of Tax from 1992 to 1996 and as Vice President of Tax and Finance from 1996 until 1997 at ICN Pharmaceuticals. Prior to ICN Pharmaceuticals, Mr. Joyce served as a Certified Public Accountant with Coopers & Lybrand and Price Waterhouse. He received a B.S. in Business Administration from the University of North Carolina at Chapel Hill in 1983 and a M.S. in Taxation from Golden State University in 1992.

Mr. Buchen has served as Senior Vice President, General Counsel and Secretary since November 2002. From November 1998 to November 2002, he served in a number of increasingly responsible positions. Prior to joining Watson, Mr. Buchen was Corporate Counsel at Bausch & Lomb Surgical (formerly Chiron Vision Corporation) from November 1995 until November 1998 and was an attorney with the law firm of Fulbright & Jaworski, LLP. Mr. Buchen received a B.A. in Philosophy from the University of California, Berkeley in 1985, and a Juris Doctor with honors from George Washington University Law School in 1989.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a global integrated pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release.  It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties affecting Watson's business detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's annual report on Form 10-K for the year ended December 31,2010. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.CONTACTS:Investors:Patty Eisenhaur(973) 355-8141Media:Charlie Mayr(973) 355-8483
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson to Present at the Barclays 2011 Global Healthcare Conference
2. Watson to Present at the Cowen & Company 31st Annual Healthcare Conference
3. Watson to Present at the 2011 Citi Global Healthcare Conference
4. Watson Fourth Quarter 2010 Net Revenue Increases 21% to $953 Million
5. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
6. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2010 Earnings
7. Watson Confirms Welchol® Oral Suspension Patent Challenge
8. Watson Presents Outlook for Continued Long Term Growth
9. Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
10. Watson Announces Preliminary Financial Performance for FY 2010
11. Watson to Host Investor Day on January 21 in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016  Syneron Medical Ltd. (NASDAQ: ... announced today that William Griffing , Chief ... scheduled to participate in the Leerink Partners 5 ... 11, 2016 in New York City ... to meet with the Mr. Griffing and will ...
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... announced the addition of the "Global ... financials" company profile to their offering. ... announced the addition of the "Global ... financials" company profile to their offering. ...
(Date:2/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... underwritten secondary offering of 11,027,558 shares of its common ... of Blackstone and Goldman Sachs.  The shares are being ... $96.45 per share. The selling stockholders will receive all ... nor any of its directors, officers or other stockholders ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Steven Tonkinson, 36, of Coconut Grove, ... year since it started in 2003. This year, he ran all 26.2 miles with ... and NBA team the Miami Heat. , This Sunday, while many are watching the ...
(Date:2/5/2016)... Minneapolis, MN (PRWEB) , ... February 05, 2016 , ... ... p.m. at the Day Block Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will ... , Larry Schneiderman, owner of Schneiderman’s Furniture, lives with Parkinson’s disease and is the ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the routine: each ... longer to access the treadmills. It’s a predictable trend. After the excesses of November ... get in shape by joining gyms, starting new walking or running routines, or signing ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Dr. Justin Scott ... their 2nd Annual No Cost Dental Day to individuals in need. The event is ... of this No Cost Dental Day is to provide dental care to community members ...
Breaking Medicine News(10 mins):